Search Results: zolgensma

December Webinar on SMA Treatments and Clinical Trials Now Available Online

Posted in , ,

A recording of the December 13th webinar updating the community on SMA treatments and clinical trials is now available online. A PDF of the webinar […]

Read More ›

Advocacy Year-in-Review 2018

Posted in , ,

For Cure SMA, 2018 has been a year of great progress. As we continue to make strides into 2019, it is important to take a […]

Read More ›

AveXis Issues Community Statement on BLA Acceptance

Posted in , ,

AveXis has provided the following community statement on the BLA submission and acceptance for their investigational therapy, AVXS-101 – now known as ZOLGENSMA®. Dear SMA […]

Read More ›

Novartis Announces FDA Filing Acceptance and Priority Review for AVXS-101

Posted in , ,

Novartis today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) for AVXS-101, now known as ZOLGENSMA® […]

Read More ›
Scroll to Top